Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders

Journal of Cutaneous Pathology

Volumn 28, Issue 9, 2001, Pages 448-452

  Kamarashev, Jivko ^a   Schaerer, Leo ^a   Burg, Günter ^a   Schmid, Monika Hess ^a   Müller, Beatrix ^a   Kempf, Werner ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ANTIGEN; IMMUNOGLOBULIN;

ARTICLE; B CELL LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISEASE; MICROSCOPY; T LYMPHOCYTE;

ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, B-CELL; MEMBRANE PROTEINS; POLY(A)-BINDING PROTEINS; PROTEINS; PSEUDOLYMPHOMA; RNA-BINDING PROTEINS; SKIN NEOPLASMS;

EID: 0034835174     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2001.028009448.x     Document Type: Article

References (20)

1. Cutaneous lymphomas
2. Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas
3. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis
4. Evidence for an involvement of T4+ cytotoxic T cells in tumor immunity
5. Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma
6. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration
7. CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides
8. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease
9. A polyadenylate-binding protein localized to the granules of cytolytic lymphocytes induces DANN fragmentation in target cells
10. Angiogenesis in cutaneous lymphoproloferative disorders: Microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas
11. Auto-tumor reactive cytotoxic T-cell responses in B-cell non-Hodgkin's lymphoma
12. Autotumour reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non-Hodgkin's lymphomas
13. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival
14. Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell lymphomas and pseudolymphomas
15. The cell population of cutaneous B-cell lymphomas
16. T-cell population of primary and secondary cutaneous B-cell lymphomas does not express the cutaneous lymphocyte-associated antigen (CLA)
17. T cells infiltrating non-Hodgkin's B-cell lymphomas show altered tyrosine phosphorylation pattern even though T-cell receptor/CD3-associated kinases are present
18. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
19. Vaccination as immunotherapy for B-cell lymphoma
20. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells